Adam Feuerstein

TheStreet.com Senior Columnist

Before joining TheStreet.com in March 2001, Feuerstein covered business software for Upside.com. Prior to that he covered a variety of business beats, including technology and commercial real estate, at the San Francisco Business Times.

Feuerstein graduated from Emory University with a bachelor's degree in political science.

Adam Feuerstein
By This Author:
« Back
Page 1 of 6
Video

Top Biotech Stock Picks

By Alix Steel | By Adam Feuerstein

From the Best of TSC TV: BOSTON (TheStreet) - Adam Feuerstein, senior biotech reporter, talks swine flu, small cap stock, healthcare reform, speculative stocks and Dendreon. Watch this video to see Adam's top biotech stock picks. original air date: 09/29/2009.

05:00PM 10/04/09

Video

Biotech Lightning Round

By Alix Steel | By Adam Feuerstein

BOSTON (TheStreet) -- Adam Feuerstein, senior biotech reporter, breaks down the biotech stocks you want to know about and how to trade them.

12:00PM 10/02/09

Video

Biotech Safe from Congress

By Alix Steel | By Adam Feuerstein

BOSTON (TheStreet) -- Adam Feuerstein argues that biotech will be safe from any pending healthcare reform. Watch this video to see what big cap stocks Adam thinks investors will flock to.

12:00PM 10/01/09

Video

Stocks Under $10: Biotech

By Adam Feuerstein | By Alix Steel

BOSTON (TheStreet) -- Adam Feuerstein, senior biotech reporter, reveals his three favorite biotech stocks under $10.

12:12PM 09/30/09

Video

Top Biotech Stock Picks

By Alix Steel | By Adam Feuerstein

BOSTON (TheStreet) - Adam Feuerstein, senior biotech reporter, talks swine flu, small cap stock, healthcare reform, speculative stocks and Dendreon. Watch this video to see Adam's top biotech stock picks.

02:12PM 09/29/09

Video

Swine Flu Expectation Game

By Bill McCandless | By Adam Feuerstein

Adam Feuerstein explains why swine flu stocks offer short-term trading opportunities but should be avoided as long-term investments.

12:00PM 09/13/09

Video

Swine Flu Expectation Game

By Bill McCandless | By Adam Feuerstein

BOSTON (TheStreet) -- Adam Feuerstein tackles investing versus trading in the swine flu stocks and explains just how you should look at it.

05:00AM 09/10/09

Video

Risk-Reward Favors Xoma

By Adam Feuerstein

Adam Feuerstein gives two reasons why a beaten-down biotech is poised for a comeback.

06:00PM 08/22/09

Video

Risk-Reward Favors Xoma

By Adam Feuerstein

Adam Feuerstein gives two reasons why a beaten-down biotech is poised for a comeback.

09:00AM 08/19/09

Video

Stay Away From Antigenics

By Adam Feuerstein

This is one cancer vaccine stock that's more hype than substance.

06:00PM 08/08/09

« Back
Page 1 of 6
Dow Jones S&P 500 NASDAQ 10-Year Note
10,464.40 1,110.63 2,176.05 32.79
Oil *
77.05
UP
30.69
UP
4.98
UP
6.87
DOWN
0.38
10 Yr
3.28%
SPDR Gold
116.62
+0.29%
+0.45%
+0.32%
-1.15%
Data delayed 20 minutes

Brokerage Partners